17956293|t|Interleukin-1 and inflammatory neurodegeneration.
17956293|a|Inflammation occurs rapidly in response to acute brain insults such as stroke, haemorrhage or trauma, and can be sustained for long periods of time, for example in Alzheimer's or Parkinson's diseases and multiple sclerosis. Experimental evidence indicates that inflammation plays a major role in neurodegeneration under these conditions, and that the cytokine IL-1 (interleukin-1) is a pivotal mediator. IL-1 is expressed rapidly in response to neuronal injury, predominantly by microglia, and elevated levels of endogenous or exogenous IL-1 markedly exacerbate injury. The naturally occurring IL-1RA (IL-1 receptor antagonist) markedly inhibits ischaemic, excitotoxic and traumatic brain injury in rodents, and has shown promise in a Phase II clinical trial in stroke patients. The mechanisms of IL-1 expression, release and action in neurodegeneration are not fully elucidated and appear multiple. Systemic IL-1 markedly enhances ischaemic brain injury via release of neutrophils into circulation, neutrophil adhesion to injured cerebrovasculature and CNS (central nervous system) invasion, and cell death via activation of matrix metalloproteinase-9. IL-1 also influences the release of toxins from glial and endothelial cells. Neuronal responses to excitotoxins and physiological factors may have an impact on neuronal survival. IL-1RA, delivered peripherally, can enter the CNS in animals and humans and has no adverse effects in stroke or subarachnoid haemorrhage patients, but shows potential benefit in acute stroke patients.
17956293	0	13	Interleukin-1	Gene	3552
17956293	18	48	inflammatory neurodegeneration	Disease	MESH:D018746
17956293	50	62	Inflammation	Disease	MESH:D007249
17956293	99	112	brain insults	Disease	MESH:D001927
17956293	121	127	stroke	Disease	MESH:D020521
17956293	129	140	haemorrhage	Disease	MESH:D006470
17956293	144	150	trauma	Disease	MESH:D014947
17956293	214	249	Alzheimer's or Parkinson's diseases	Disease	MESH:D010300
17956293	254	272	multiple sclerosis	Disease	MESH:D009103
17956293	311	323	inflammation	Disease	MESH:D007249
17956293	346	363	neurodegeneration	Disease	MESH:D019636
17956293	410	414	IL-1	Gene	3552
17956293	416	429	interleukin-1	Gene	3552
17956293	454	458	IL-1	Gene	3552
17956293	495	510	neuronal injury	Disease	MESH:D009410
17956293	587	591	IL-1	Gene	3552
17956293	644	650	IL-1RA	Gene	3557
17956293	652	676	IL-1 receptor antagonist	Gene	3557
17956293	696	705	ischaemic	Disease	MESH:D018917
17956293	707	718	excitotoxic	Disease	
17956293	723	745	traumatic brain injury	Disease	MESH:D000070642
17956293	812	818	stroke	Disease	MESH:D020521
17956293	819	827	patients	Species	9606
17956293	847	851	IL-1	Gene	3552
17956293	886	903	neurodegeneration	Disease	MESH:D019636
17956293	959	963	IL-1	Gene	3552
17956293	982	1004	ischaemic brain injury	Disease	MESH:D001930
17956293	1176	1202	matrix metalloproteinase-9	Gene	4318
17956293	1204	1208	IL-1	Gene	3552
17956293	1383	1389	IL-1RA	Gene	3557
17956293	1448	1454	humans	Species	9606
17956293	1485	1491	stroke	Disease	MESH:D020521
17956293	1495	1519	subarachnoid haemorrhage	Disease	MESH:D013345
17956293	1520	1528	patients	Species	9606
17956293	1561	1573	acute stroke	Disease	MESH:D020521
17956293	1574	1582	patients	Species	9606
17956293	Negative_Correlation	MESH:D000070642	3557
17956293	Association	MESH:D018746	3552
17956293	Negative_Correlation	MESH:D018917	3557
17956293	Association	MESH:D009410	3552
17956293	Positive_Correlation	MESH:D001930	3552
17956293	Positive_Correlation	3552	4318

